17,195
edits
Changes
no edit summary
Recently approved by the [[FDA]], '''postmortem chemotherapy''' is a radical form of medical treatment in which "a ray of hope is offered to those who are no longer with us" by administering chemotherapy anywhere within 1 month and up to 5 years after a patient's death."<ref>[http://gomerblog.com/2017/01/fda-approves-groundbreaking-postmortem-chemotherapy-protocol/ FDA Approves Groundbreaking Postmortem Chemotherapy Protocol(Gomerblog)]</ref> '''Types'''----The '''postmortem chemotherapy''' regimens available are varied depending on the type of metastatic cancer that killed the patient. '''Patient Selection'''----Candidates for '''postmortem chemotherapy''' most undergo a rigorous selection process during which they must prove their lack of functional status with an ECOG status of 5 but still show they are clearly still "a fighter."<ref>[http://gomerblog.com/2016/11/hospital-morgue/ Hospital Morgue Morning Rounds Initiated After Family Insists Patient “is a Fighter”(Gomerblog)]</ref> Patients usually must undergo [[Transthoracic Echocardiogram|transthoracic echocardiogram]] (or [[Amazon Echocardiogram|TTE]]) in order to monitor for and avoid cardiotoxicity as is the case with doxorubicin-based '''postmortem chemotherapy''' regimens. '''Drug Monitoring'''----Typically, decreased patients are given '''postmortem chemotherapy''' in the outpatient setting where skilled health care professionals look for the presence of [[Vital Signs|vital signs]]. '''Does It Work?'''----If '''postmortem chemotherapy''' continues its current rate of success, then, by the end of 2017, 100% of decreased patients should remain dead. '''Other Reading'''----* [[Autoimmune]]* [[Chemotaxis]]* [[Mass]]* [[Pork Chop]]* [[Postmortem Antibiotics]]* [[Remission]]* [[Terminal Illness]]